These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23535921)

  • 1. Priorities for improving drug research, development and regulation.
    Forda SR; Bergström R; Chlebus M; Barker R; Andersen PH
    Nat Rev Drug Discov; 2013 Apr; 12(4):247-8. PubMed ID: 23535921
    [No Abstract]   [Full Text] [Related]  

  • 2. Reproducibility: Team up with industry.
    Edwards A
    Nature; 2016 Mar; 531(7594):299-301. PubMed ID: 26983524
    [No Abstract]   [Full Text] [Related]  

  • 3. A better prescription for drug-development financing.
    Kessel M; Frank F
    Nat Biotechnol; 2007 Aug; 25(8):859-66. PubMed ID: 17687358
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
    Laverty H; Gunn M; Goldman M
    Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
    [No Abstract]   [Full Text] [Related]  

  • 5. Reflections on the Innovative Medicines Initiative.
    Goldman M
    Nat Rev Drug Discov; 2011 May; 10(5):321-2. PubMed ID: 21532547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development speed paradox: can increasing development speed reduce R&D productivity?
    Lendrem DW; Lendrem BC
    Drug Discov Today; 2014 Mar; 19(3):209-14. PubMed ID: 24051396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug giants hamstrung by timid middle management.
    Firestone RA
    Nature; 2006 May; 441(7091):282. PubMed ID: 16710394
    [No Abstract]   [Full Text] [Related]  

  • 8. Driving external chemistry optimization via operations management principles.
    Bi FC; Frost HN; Ling X; Perry DA; Sakata SK; Bailey S; Fobian YM; Sloan L; Wood A
    Drug Discov Today; 2014 Mar; 19(3):289-94. PubMed ID: 23973340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level.
    Kamel N; Compton C; Middelveld R; Higenbottam T; Dahlén SE
    Eur Respir J; 2008 May; 31(5):924-6. PubMed ID: 18448501
    [No Abstract]   [Full Text] [Related]  

  • 10. India's patent ecosystem - encouraging strong patents or discouraging innovation?
    Harrison C
    Nat Rev Drug Discov; 2013 Oct; 12(10):732-3. PubMed ID: 24080690
    [No Abstract]   [Full Text] [Related]  

  • 11. Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
    Forster SP; Stegmaier J; Spycher R; Seeger S
    Drug Discov Today; 2014 Mar; 19(3):348-55. PubMed ID: 24291787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intellectual property policies in early-phase research in public-private partnerships.
    Stevens H; Van Overwalle G; Van Looy B; Huys I
    Nat Biotechnol; 2016 May; 34(5):504-10. PubMed ID: 27153280
    [No Abstract]   [Full Text] [Related]  

  • 13. Can business and science coexist in this century?
    Ackerman W
    J Ark Med Soc; 2001 Jun; 97(12):401. PubMed ID: 11383496
    [No Abstract]   [Full Text] [Related]  

  • 14. Biopharma business models in Canada.
    March-Chordà I; Yagüe-Perales RM
    Drug Discov Today; 2011 Aug; 16(15-16):654-8. PubMed ID: 21708279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public-private partnership models in France and in Europe.
    Demotes-Mainard J; Canet E; Segard L
    Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celgene samples from science smorgasbord.
    Mullard A
    Nat Biotechnol; 2015 Sep; 33(9):892-3. PubMed ID: 26348944
    [No Abstract]   [Full Text] [Related]  

  • 17. The Brazilian phytotherapics industry: challenges and opportunities.
    Hasenclever L; Paranhos J; Costa CR; Cunha G; Vieira D
    Cien Saude Colet; 2017 Aug; 22(8):2559-2569. PubMed ID: 28793072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jean-Jacques Garaud. Interview by Bethan Hughes.
    Garaud JJ
    Nat Rev Drug Discov; 2010 Aug; 9(8):588. PubMed ID: 20671757
    [No Abstract]   [Full Text] [Related]  

  • 20. Escaping the pincer.
    Nat Rev Drug Discov; 2009 Dec; 8(12):915. PubMed ID: 19967796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.